CLINICAL_TRIALS
trial_result
· 2020-04-14
Clinical Trial Update: A Safety and Tolerability Study of RJX Drug Product in Healthy Participants [Phase 1]
Summary
Phase 1 safety and tolerability trial of RJX Drug Product in healthy participants has completed; results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Reven Pharmaceuticals, Inc. | Conditions: Critical Limb Ischemia | Phase 1 | Status: COMPLETED | Results posted: 2020-04-14